Abstract |
8319, ((+-)-2-Amino-N-ethyl-alpha-(3-methyl-2-thienyl)benzeneethanamine 2HCl), is a novel compound with the profile of a non-competitive NMDA antagonist. The compound displaced [3H] TCP with high affinity (IC50 = 43 nM), but was inactive at the NMDA, benzodiazepine and GABA sites; in vivo, 8319 showed good efficacy as an anticonvulsant and potential neuroprotective agent. It blocked seizures induced by NMDLA, supramaximal electroshock, pentylenetetrazol (PTZ), picrotoxin, and thiosemicarbazide with ED50's of 1-20 mg/kg ip. As a neuroprotective agent, 8319 (30-100 mg/kg sc) prevented the death of dorsal hippocampal pyramidal cells induced by direct injection of 20 nmol NMDA. At 15 mg/kg ip, the compound was also effective against hippocampal neuronal necrosis induced via bilateral occlusion of the carotid arteries in gerbils. In summary, 8319 is a noncompetitive NMDA antagonist with good anticonvulsant activity and may possess neuroprotective properties useful in the treatment of brain ischemia.
|
Authors | S Fielding, J C Wilker, J Chernack, V Ramirez, C A Wilmot, L L Martin, J F Payack, M L Cornfeldt, K A Rudolphi, D K Rush |
Journal | Progress in clinical and biological research
(Prog Clin Biol Res)
Vol. 361
Pg. 533-41
( 1990)
ISSN: 0361-7742 [Print] United States |
PMID | 2290851
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Aniline Compounds
- Anticonvulsants
- Thiophenes
- Tritium
- compound 8319
- N-Methylaspartate
- Dizocilpine Maleate
|
Topics |
- Aniline Compounds
(metabolism, pharmacology, therapeutic use)
- Animals
- Anticonvulsants
(pharmacology, therapeutic use)
- Binding, Competitive
- Brain Diseases
(prevention & control)
- Brain Ischemia
(drug therapy)
- Dizocilpine Maleate
(metabolism, pharmacology)
- Gerbillinae
- Hippocampus
(drug effects)
- Male
- Mice
- Mice, Inbred Strains
- N-Methylaspartate
(antagonists & inhibitors, toxicity)
- Rats
- Rats, Inbred Strains
- Thiophenes
(metabolism, pharmacology, therapeutic use)
- Tritium
|